Excursions in biomedical mass spectrometry

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 119-126

  Taylor, Graham W ^a   Donnelly, Louise E ^a,b   Murray, Stephen ^a   Rendell, Nigel B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

ADP ribosylation; Aspergillus fumigatus; Electrospray; Gliotoxin; Helicobacter pylori; Mevalonic acid; Pseudomonas aeruginosa; SAP; Steroid; Sulphate

Indexed keywords

CILIOTOXIN; GLIOTOXIN; MEVALONIC ACID; MYCOTOXIN; STEROID; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; CONFERENCE PAPER; DRUG ANALYSIS; GAS CHROMATOGRAPHY; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA;

EID: 0029902101     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.36916.x     Document Type: Conference Paper

References (37)

1. Dollery CT, Davies DS, Draffan GH, Williams FM, Conolly ME. Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet 1970; ii: 1164-1166.
2. Chalmers JP, Davies DS, Draffan GH, Reid JL, Thorgeirsson SS. Demethylation of 3-O-methyldopa. Br J Pharmacol 1971; 43: 455P-456P.
3. Blair IA, Barrow SE, Waddell KA, Lewis PJ, Dollery CT. Prostacyclin is not a circulating hormone in man. Prostaglandins 1982; 23: 579-589.
4. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985; 318: 186-188.
5. Barrow SE, Ward PS, Sleightholm MA, Ritter JM, Dollery CT. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Biochim Biophys Acta 1989; 993: 121-127.
6. 2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 1991; 143: 119-125.
7. 2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 1991; 100: 1069-1077.
8. Davies DS, Kahn GC, Murray S, Brodie MJ, Boobis AR. Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Br J Clin Pharmacol 1981; 11: 89-91.
9. Speirs CJ, Murray S, Davies DS, Biola Mabadeje AF, Boobis AR. Debrisoquine oxidation phenotype and susceptibility to lung cancer. Br J Clin Pharmacol 1990; 29: 101-109.
10. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, Murray S. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef [see comments]. Cancer Res 1992; 52: 6216-6223.
11. Gooderham NJ, Murray S, Lynch AM, et al. Heterocyclic amines: evaluation of their role in diet associated cancer. Br J Clin Pharmacol 1996; 42: 91-98.
12. Sullivan MH, Roseblade CK, Rendell NB, Taylor GW, Elder MG. Metabolism of prostaglandins E2 and F2 alpha by human fetal membranes. Biochim Biophys Acta 1992; 1123: 342-346.
13. Zosmer A, Rendell NB, Taylor GW, Elder MG, Sullivan MHF. Formation and metabolism of 14,15-epoxyeicosatrienoic acid by human reproductive tissues. Biochim Biophys Acta 1995; 1258: 234-240.
14. Sehmi R, Cromwell O, Taylor GW, Kay AB. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5.9,11, 13(Z,E,Z,E)-eicosatetraenoic acid. J Immunol 1991; 147: 2276-2283.
15. Budd T, Clinton P, Dell A, et al. Isolation and characterisation of glutamate receptor antagonists from venoms of orb-web spiders. Brain Res 1988; 448: 30-39.
16. Morris HR, Masento MS, Taylor GW, Jermyn KA, Kay RR. Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. Biochem J 1988; 249: 903-906.
17. Morandini P, Offer J, Traynor D, et al. The proximal pathway of metabolism of the chlorinated signal molecule differentiation-inducing factor-1 (DIF-1) in the cellular slime mould Dictyostelium. Biochem J 1995; 306: 735-743.
18. Khoo KH, Maizels RM, Page AP, Taylor GW, Rendell NB, Dell A. Characterization of nematode glycoproteins: the major O-glycans of Toxocara excretory-secretory antigens are O-methylated trisaccharides. Glycobiology 1991; 1: 163-171.
19. Masento MS, Taylor GW, Watson D, et al. Metabolism of 3-hydroxychrysene by rat liver microsomal preparations. Chem Biol Interact 1990; 74: 163-178.
20. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988; 56: 2515-2517.
21. Somerville M, Taylor GW, Watson D, et al. Release of mucus glycoconjugates by Pseudomonas aeruginosa rhamnolipid into feline trachea in vivo and human bronchus in vitro. Am J Respir Cell Mol Biol 1992; 6: 116-122.
22. Scoppola A, Maher VM, Thompson GR, Rendell NB, Taylor GW. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J Lipid Res 1991; 32: 1057-1060.
23. Naoumova RP, Marais AD, Mountney J, et al. Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. Atherosclerosis 1996; 119: 203-213.
24. Naoumova R, Cummings MH, Watts GF, et al. Acute hyperinsulinaemia decreases cholesterol synthesis less in NIDDM than in non diabetic patients. Eur J Clin Invest 1996; 26: 332-340.
25. Mazzone T, Foster D, Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 1984; 33: 333-338.
26. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705-708.
27. Deprez PH, Ghosh P, Goodlad RA, et al. Hypergastrinaemia: a new mechanism. Lancet 1991; 338: 410-411.
28. Lacey SL, Mehmet S, Taylor GW. Inhibition of Helicobacter pylori growth by 4-hydroxy-2- alkylquinolines produced by Pseudomonas aeruginosa. J Antimicrob Chemother 1995; 36: 827-831.
29. Taylor GW, Machan ZA, Mehmet S, Cole PJ, Wilson R. Rapid identification of 4-hydroxy-2-alkylquinolines produced by Pseudomonas aeruginosa using gas chromatography-electron-capture mass spectrometry. J Chromatogr B Biomed Appl 1995; 664: 458-462.
30. Vestal ML. Thermospray liquid chromatographic interface for magnetic mass spectrometers. Anal Chem 1984; 56: 2590-2592.
31. Murray S, Rendell NB, Taylor GW. Microbore h.p.l.c. electrospray ionisation mass spectrometry of steroid sulphates. J Chromatogr 1996; in press.
32. Orie NGM, de Vries GA, Kikstra A. Growth of aspergillus in the human lung. Aspergilloma and aspergillosis. Am Rev Respir Dis 1960; 82: 649-662.
33. Amitani R, Taylor G, Elezis EN, et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63: 3266-3271.
34. Allport J, Donnelly LE, Kefatas P, et al. A possible role for mono(ADP-ribosyl)transferase in the signalling pathway mediating neutrophil chemotaxis. Br J Clin Pharmacol 1996; 42: 99-106.
35. Donnelly LE, Rendell NB, Murray S, et al. Arginine specific mono(ADP-ribosyl)transferase activity on the surface of human polymorphonuclear neutrophil leucocytes. Biochem J 1996; 315: 635-641.
36. Hutchinson WL, Noble GE, Hawkins PN, Pepys MB. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 1994; 94: 1390-1396.
37. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 1995; 92: 4299-4303.